Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,923 GBX | -0.05% | +5.61% | +7.38% |
Apr. 26 | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
Apr. 25 | Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024 | CI |
ETFs positioned on Hikma Pharmaceuticals PLC
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,120 M€ | -0.11% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - | |
0.16% | 18 M€ | +2.87% | - | |
0.15% | 5 M€ | +10.09% | - | |
0.15% | 14 M€ | +5.66% | - | |
0.04% | 6 M€ | -.--% | ||
0.02% | 10 M€ | -3.35% | - | |
0.01% | 31 M€ | +2.75% | - | |
0.01% | 284 M€ | -.--% | ||
0.01% | 206 M€ | -.--% | ||
0.01% | 1,166 M€ | +0.26% | - | |
0.01% | 607 M€ | +0.05% | - | |
0.01% | 23 M€ | -.--% | - | |
0.01% | 786 M€ | -.--% | ||
0.01% | 273 M€ | +15.93% | ||
0.00% | 389 M€ | +6.58% | - | |
0.00% | 34 M€ | +1.51% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 34 M€ | +6.29% | - | |
0.00% | 237 M€ | +1.29% | - | |
0.00% | 302 M€ | +3.73% | - | |
0.00% | 39 M€ | +4.22% | - | |
0.00% | 26 M€ | -4.26% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.38% | 5.35B | |
+34.00% | 704B | |
+27.35% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+14.91% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- HIK Stock
- Funds and ETFs Hikma Pharmaceuticals PLC